Press

Recently, the District Court in Düsseldorf lifted several ex-parte preliminary injunctions granted for Merck Sharpe & Dohme Corp. (MSD) against...

Open letter leads to dialogue The European Patent Office has started a constructive dialogue with patent attorneys and attorneys-at-law on the...

Numerous generics manufacturers are now allowed to sell their imitator preparations of the cholesterol-lowering drug Inegy in Germany. The Düsseldorf...

The so-called second medical use of medicaments is currently one of the most important topics in European patent law. The Düsseldorf Regional Court...

Out of concern for the quality of patent granting by the European Patent Office (EPO), four law firms have addressed an open letter to the current...

Patent Protection at Risk Open Letter to the European Patent Office: Quality of patent examinations at risk In an open letter to the European Patent...

The supplementary protection certificate of the US pharma company Gilead, which covers the active agent combination of the HIV medicament TRUVADA®,...

Is it required that an active or an exact active combination is explicitly mentioned in the underlying patent, in order to allow a supplementary...

Marco Stief, Partner, and Sebastian Haase, Senior Associate, have accompanied the acquisition of Pharmazeutische Fabrik Evers GmbH & Co. KG. The two...

Extended Patent Protection for Pharmaceutical Companies Prospect of Legal Certainty for all EU Member States Maiwald obtains a referral to the...